BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2974461)

  • 1. Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics.
    Abel EA; Lindae ML; Hoppe RT; Wood GS
    J Am Acad Dermatol; 1988 Dec; 19(6):1089-95. PubMed ID: 2974461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation.
    Wood GS; Abel EA; Hoppe RT; Warnke RA
    J Am Acad Dermatol; 1986 Jun; 14(6):1006-13. PubMed ID: 3088069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell.
    Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS
    Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides.
    Burke JS; Sheibani K; Rappaport H
    Am J Pathol; 1986 May; 123(2):256-63. PubMed ID: 3486598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
    Safai B
    Clin Bull; 1977; 7(4):140-5. PubMed ID: 147147
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
    Sentis HJ; Willemze R; Scheffer E
    J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
    Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
    J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
    Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
    J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia.
    Wood GS; Deneau DG; Miller RA; Levy R; Hoppe RT; Warnke RA
    Blood; 1982 May; 59(5):876-82. PubMed ID: 7042004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties in Sézary cells with an unusual phenotype.
    Bernengo MG; Meregalli M; Jemma C; Lisa F
    Clin Immunol Immunopathol; 1985 Dec; 37(3):298-311. PubMed ID: 2932270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF; Hensley LL; Jegasothy BV
    Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
    Gupta S; Safai B; Edelson R; Parrott D; Good R
    Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.
    Wood GS; Strickler JG; Deneau DG; Egbert B; Warnke RA
    J Am Acad Dermatol; 1986 Sep; 15(3):444-58. PubMed ID: 3489740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic differentiation of the Sézary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis.
    Chu AC; Robinson D; Hawk JL; Meacham R; Spittle MF; Smith NP
    J Invest Dermatol; 1986 Feb; 86(2):134-7. PubMed ID: 3528307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.